Rigel Pharmaceuticals
RIGL
#7550
Rank
€0.21 B
Marketcap
12,35 €
Share price
0.44%
Change (1 day)
20.57%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -0,21 €

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,20 €. In 2022 the company made an earnings per share (EPS) of -0,31 € a decrease over its 2021 EPS that were of -0,09024 €.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,21 €-30.45%
2022-0,31 €240%
2021-0,09024 €-37.5%
2020-0,14 €-60%
2019-0,36 €-11.11%
2018-0,41 €-26.23%
2017-0,55 €-17.57%
2016-0,67 €25.42%
2015-0,53 €-42.72%
2014-0,93 €1.98%
2013-0,91 €-24.06%
2012-1,20 €-4.32%
2011-1,25 €-290.41%
20100,66 €-126.64%
2009-2,47 €-25.14%
2008-3,30 €41.86%
2007-2,33 €70.86%
2006-1,36 €-27.4%
2005-1,88 €-33.33%
2004-2,82 €-37.73%
2003-4,52 €-31.83%
2002-6,63 €-63.55%
2001-18,19 €-96.43%
2000-510,10 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,71 € 759.09%🇺🇸 USA
-1,30 € 554.55%🇺🇸 USA
1,79 €-1,002.27%🇬🇧 UK
12,77 €-6,531.82%🇺🇸 USA